Parvovirus B19 Infection in Tunisian Patients with Sickle-Cell Anemia
Author Information
Author(s): Regaya Faouzi, Oussaief Lassad, Bejaoui Mohamed, Karoui Mongi, Zili Mohamed, Khelifa Ridha
Primary Institution: National Bone Marrow Transplantation Center, Tunis, Tunisia
Hypothesis
The study investigates the prevalence and impact of parvovirus B19 infection in Tunisian patients with chronic hemolytic anemia.
Conclusion
A new parvovirus B19 strain of genotype1 was detected in four Tunisian patients with sickle-cell anemia, likely transmitted in a hospital setting.
Supporting Evidence
- Anti-parvovirus B19 IgG antibodies were found in 56.5% of sickle-cell anemia patients.
- Only 8.7% of sickle-cell anemia patients tested positive for IgM antibodies.
- Four patients with acute erythroblastopenia were identified as acutely infected with parvovirus B19.
- The virus strain detected was identified as a new variant of genotype1.
Takeaway
Doctors found a new type of virus in some sickle-cell anemia patients in Tunisia, which they think spread in the hospital.
Methodology
The study involved 92 patients with chronic hemolytic anemia and 46 controls, using serological tests and nested PCR to detect antibodies and viral DNA.
Limitations
The study's conclusions about transmission routes are limited by the low genetic variability of the virus.
Participant Demographics
Patients were aged 2 to 19 years, with mean ages of 9.2 years for sickle-cell anemia and 7.4 years for β-thalassemia.
Statistical Information
P-Value
≤ 0.00050296
Statistical Significance
p ≤ 0.00050296
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website